HoLEP Sexual Survivorship
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT07660068
- Status
- Enrolling By Invitation
Conditions
- BPH
- Lower Urinary Tract Symptoms
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Telephone Interview — OTHERA one-time 30-45-minute telephone interview and discussion regarding the participants' after HoLEP experience and sexual satisfaction following HoLEP.
- Questionnaires over the span of 24 months — OTHERParticipants will complete questionnaires at 1, 3, 6, 12, and 24 months post-operatively
Study Details
The objective of this study is to evaluate how sexual function, ejaculatory function, and overall sexual satisfaction change following Holmium Laser Enucleation of the Prostate (HoLEP). In doing so, the study team will examine the trade-off between relief of lower urinary tract symptoms and changes in sexual function.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 252 participants (estimated)
Arms
- Arm: Focus GroupTo better assess what questions are pertinent to patient sexual satisfaction post-HoLEP, the study team will first conduct a preliminary study of 15 patients who are currently sexually active after the HoLEP procedure. The preliminary study will be conducted by a one-time 30-45-minute telephone interview and discussion regarding the participants' after HoLEP experience and sexual satisfaction following HoLEP.
- Arm: Longitudinal CohortThe main longitudinal study in which the study team will follow HoLEP patients for 24 months post-operatively. The longtiudinal study cohort is powered to detect a clinically meaningful discrepancy in symptoms after the HoLEP procedure and patient reported ratings.
Primary Outcome Measure
Ejaculatory function [ Time Frame: 1 year ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 | - |
Find similar trials in Chicago, IL
By research site
Related Studies
- Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEPPHASE3 · Recruiting · Northwestern University · Chicago, Illinois
- HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate CancerRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- BPH Global RegistryRecruiting · Société Internationale d'Urologie · Los Angeles, California